{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:40:06Z","timestamp":1761129606961,"version":"3.40.4"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Amphetamine toxicity typically presents with hypertension and tachycardia. Conversely, clonidine acts as an agonist at central \u03b12 and imidazoline receptors, which may cause brief initial hypertension followed by hypotension and bradycardia in overdose. We report a case of mixed ingestion resulting in posterior reversible encephalopathy syndrome (PRES) successfully treated with phentolamine.<\/jats:p>\n          <jats:p>A 17-year-old male adolescent presented to the emergency department 2 hours after ingesting up to 25 each of clonidine 0.1-mg tablets and dextroamphetamine 10 mg extended-release capsules. He reported nausea and fatigue with initial blood pressure (BP) 145\/95 mm Hg and heart rate (HR) 52 beats per minute (bpm). Nine hours postingestion (HPI), the patient developed headache, photophobia, and confusion with BP 182\/111 mm Hg and HR 48 bpm. A computed tomography scan of the head revealed generalized fullness of the cerebellum, upward bulging of the tentorial leaflets, effacement of the fourth ventricle, and crowding of the foramen magnum, suspicious for an atypical presentation of PRES. The patient's systolic BP rose over 200 mm Hg and treated with 2 mg of intravenous phentolamine at 14 HPI. Blood pressure decreased to 133\/82 mm Hg, and HR increased to 56 bpm with improvements in headache. Following repeat doses of phentolamine, nicardipine was initiated and increased to 2.5 mg\/h for 12 hours. The patient was stable with normal vital signs at 36 HPI.<\/jats:p>\n          <jats:p>The delayed presentation of hypertensive emergency with PRES may have been due to the actions of extended-release dextroamphetamine and the \u03b12-agonistic effects of clonidine. Phentolamine was chosen for its \u03b11-antagonism and was effective in managing symptoms.<\/jats:p>","DOI":"10.1097\/pec.0000000000001819","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T14:43:01Z","timestamp":1554993781000},"page":"e1721-e1723","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Amphetamine and Clonidine Toxicity Resulting in Posterior Reversible Encephalopathy Syndrome"],"prefix":"10.1097","volume":"37","author":[{"given":"Faisal Syed","family":"Minhaj","sequence":"first","affiliation":[{"name":"Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel F.","family":"Schult","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dvorak","sequence":"additional","affiliation":[{"name":"Imaging Sciences, University of Rochester Medical Center, Rochester, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Nacca","sequence":"additional","affiliation":[{"name":"Emergency Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"key":"bib1-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0885066610393634","article-title":"Posterior reversible encephalopathy syndrome","volume":"27","year":"2012","journal-title":"J Intensive Care Med"},{"key":"bib2-20250504","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features","volume":"29","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib3-20250504","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1542\/peds.2014-2325","article-title":"PRES in children undergoing hematopoietic stem cell or solid organ transplantation","volume":"135","year":"2015","journal-title":"Pediatrics"},{"key":"bib4-20250504","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jps.2600580436","article-title":"Amphetamine blood and urine levels in man","volume":"58","year":"1969","journal-title":"J Pharm Sci"},{"key":"bib5-20250504","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/009127009603601108","article-title":"Comparison of methods for the assessment of central nervous system stimulant response after dextroamphetamine administration to healthy male volunteers","volume":"36","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"bib6-20250504","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/j.1552-4604.1998.tb04395.x","article-title":"Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers","volume":"38","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"bib7-20250504","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cpt1977215593","article-title":"Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine","volume":"21","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"bib8-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/j.1552-4604.1994.tb03996.x","article-title":"Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects","volume":"34","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"bib9-20250504","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00609752","article-title":"Pharmacokinetics and side-effects of clonidine","volume":"13","year":"1978","journal-title":"Eur J Clin Pharmacol"},{"key":"bib12-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(67)90080-5","article-title":"Investigations into the mechanism of the hypotensive effect of 2-(2, 6-dichlorphenylamino)-2-imidazoline-HCl","volume":"2","year":"1967","journal-title":"Eur J Pharmacol"},{"key":"bib13-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/cap.1995.5.155","article-title":"Combining methylphenidate and clonidine: the role of post-marketing surveillance","volume":"5","year":"1995","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"bib15-20250504","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00002018-199819020-00003","article-title":"Comparative tolerability profile of hypertensive crisis treatments","volume":"19","year":"1998","journal-title":"Drug Saf"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T20:06:19Z","timestamp":1746389179000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000001819","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"type":"electronic","value":"1535-1815"},{"type":"print","value":"0749-5161"}],"subject":[],"published":{"date-parts":[[2019,4,10]]}}}